Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Ap... (future products based on the exciting CD...)

HOME >> MEDICINE >> TECHNOLOGY

Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications

Date:1/16/2012

future products based on the exciting CDT platform, which represents a tremendous complement to our overall value proposition as the leaders in entry site management and lesion access," said James Rushworth, Senior Vice President and General Manager, Terumo Medical Corporation and President, Onset Medical Corporation. "CDT literally changes the way physicians enter the vascular system and manage the access site, while allowing them to achieve easier, safer access to the target lesion in a variety of clinical applications. This strategic acquisition reinforces our commitment to pursuing unique technologies that meet the specialized needs of our customers and contribute to better outcomes for their patients."

As a global leader in vascular access management, TIS can effectively maximize the potential of the CDT-based platform when compared with competitors who do not specialize in entry site management.

"When Terumo approached us, it quickly became clear that they were the established leader in entry site management and the best company to commercialize our sheath technology on a global scale," said Joseph Bishop, Vice President and Chief Operating Officer, Onset Medical Corporation. "It is gratifying to know that our unique devices will immediately strengthen their core capability and will be featured prominently among other class-leading technologies that drive better patient outcomes."

For more information, contact Robert Murphy, The Storch-Murphy Group, 908.276.0777.

Terumo Interventional Systems

Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures. Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists, and Vascular Surgeons are amo
'/>"/>

SOURCE Terumo Americas Holding, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
2. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
3. Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
6. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
7. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
8. Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Society of Thoracic Surgeons Annual Meeting
9. Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
10. VirtuoSaph® Plus Endoscopic Vessel Harvesting System from Terumo Continues the Advancement of the Minimally Invasive Technique for Coronary and Peripheral Artery Bypass Grafting
11. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements

Post Your Comments:

(Date:5/21/2013)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... specialty hospital management solution provider and operator of the ... China and the parent of Chang,an Hospital, today reported ... ended March 31, 2013 [1] . First ... consists of net revenues generated from the network business ...

(Date:5/21/2013)... FRANCISCO , May 21, 2013 ... of the American Psychiatric Association show that the ... and clinically meaningful response and remission in patients ... phase of therapy, which were maintained through one ... treatment, 62 percent of patients achieved symptomatic improvement ...

(Date:5/21/2013)... N.Y., May 21, 2013 Lakeland Industries, Inc. ... manufacturer of industrial protective clothing for industry, municipalities, ... and local levels, today announced that the Company ... a Senior Credit Facility subject to certain terms ... this financing. However, no assurances can be given ...

[0] Concord Medical Reports First Quarter 2013 Financial Results [0] New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System [0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results

... demonstrate favorable safety and tolerability profile, ROCKVILLE, ... VNDA ) announced today that data from four ... an investigational atypical,antipsychotic, is associated with significantly greater ... has a favorable safety and,tolerability profile. These results ...

... Mothers, to Protect Themselves and Their Families This ... and Every Year ... WHAT: Kristi Yamaguchi, Olympic Gold Medalist ... LaShell Griffin, Oprah,s Pop Star Challenge Winner, ...

Cached Medicine Technology:Vanda Presents Phase III Iloperidone Efficacy Data 2 Vanda Presents Phase III Iloperidone Efficacy Data 3 Vanda Presents Phase III Iloperidone Efficacy Data 4 Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season 2 Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season 3

Vanda Presents Phase III Iloperidone Efficacy Data Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season

(Date:5/22/2013)... France: Results from a large observational study ... bivalirudin is superior to heparin in the ... mortality in patients with non-ST segment elevation ... intervention (PCI)., European and US NSTE-ACS guidelines ... to unfractionated heparin plus GP IIb/IIIa receptor ...

(Date:5/22/2013)... 2013 The PreDiabetes Center of ... the Greater Philadelphia Tour de Cure, a premier cycling event ... passionate about stopping the spread of diabetes , a ... , The Tour de Cure will take place Saturday, June ... in Ambler, 30 minutes outside of Philadelphia, between the hours ...

(Date:5/22/2013)... New York (PRWEB) May 22, 2013 According ... Culture, Consequences, and Cost ” article published recently at FinancesOnline.com ... fully justified. The Centers for Disease Control and Prevention ... aged 20 and over are overweight, 35.7% are obese, and ... highlighted in this investigative article. In particular, the article focuses ...

(Date:5/22/2013)... Georgia (PRWEB) May 22, 2013 ... finalists for its Better Play & Recreation Contest, ... hundreds of thousands of youth, people with disabilities, ... need of rescue. The general public is encouraged ... to help their favorite non-profit organization win the ...

(Date:5/22/2013)... City, NJ (PRWEB) May 22, 2013 ... compliance, and management solutions for social enterprise collaboration ... LLC, a consulting firm based in Chicago, Ill. ... integrate their products and provide best-in-class solutions for ... and improve collaboration. , AvePoint’s DocAve Software ...

Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2 Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2 Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3 Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 2 Health News:Black American Obesity Examined In The Latest FinancesOnline.com Article 3 Health News:Public Voting Opens for Finalists in Synthetic Turf International’s Better Play & Recreation Contest 2 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3

[0] Registry questions superiority of bivalirudin over heparin [0] PreDiabetes Centers to Appear at the Philadelphia Tour de Cure [0] Black American Obesity Examined In The Latest FinancesOnline.com Article [0] Public Voting Opens for Finalists in Synthetic Turf International’s Better Play & Recreation Contest [0] AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration

... intra-aortic balloon pumps prior to angioplasty in patients with ... of heart muscle damage, a condition referred to as ... Duke University Medical Center researchers. The findings ... the American Medical Association ( JAMA ), and ...

... , MONDAY, Aug. 29 (HealthDay News) -- Although older ... may not be making good decisions about their coverage, ... -- particularly those with impaired brain function -- can ... plans available to them, preventing them from finding the ...

... , MONDAY, Aug. 29 (HealthDay News) -- The width ... performs, according to a new study. Researchers compared the ... their companies, financial performance. The study included only men because ... behavior applies only to men. The firms of CEOs ...

... agree that financial constraints and an aging population will require ... find that pushing back the eligibility age could be a ... most. The consequences both positive and negative of ... presented in the latest installment of the Public Policy & ...

... Caution is required when deciding whether to stop life support ... Researchers examined death rates after life support was ... brain injury in six trauma centers in the Canadian provinces ... the patients died in hospital, but the rate varied from ...

... EMPHASIS-HF study showed significant reductions in death and hospitalization ... failure (CHF) and mild symptoms treated with eplerenone in ... and standard therapy. Commenting on the findings presented ... Cardiology Congress (ESC) Hot Line Session on 29th August ...

Cached Medicine News:Health News:Study shows balloon pump use prior to angioplasty does not reduce heart muscle damage 2 Health News:Some Older Americans Overwhelmed by Medicare Options, Study Says 2 Health News:Some Older Americans Overwhelmed by Medicare Options, Study Says 3 Health News:Aging authorities differ on tweaks to Social Security's benefit structure 2 Health News:Use Caution in Ending Life Support for Brain-Injured, Experts Say 2 Health News:The effect of eplerenone vs. placebo on cardiovascular mortality 2 Health News:The effect of eplerenone vs. placebo on cardiovascular mortality 3

Study shows balloon pump use prior to angioplasty does not reduce heart muscle damage Some Older Americans Overwhelmed by Medicare Options, Study Says Is Shape of CEO's Face a Measure of Power?Aging authorities differ on tweaks to Social Security's benefit structure Use Caution in Ending Life Support for Brain-Injured, Experts Say The effect of eplerenone vs. placebo on cardiovascular mortality

... wide range of Platelet aggregometers allows ... meet particular needs. Single, dual and ... chart recorder outputs or digital computer ... Optical aggregometers, which measure platelet aggregation ...

... The PAP-4C is a four channel platelet ... available: chromogenic assays, von Willebrand assay (Ristocetin ... PAP-4C may also be used for the ... (HIT). Four channels allow four tests to ...

Express Plus analyzer is a great choice for small and medium workloads....

Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....

Medicine Products:

Series 400 Aggregometers PAP-4C Express Plus Iron / TIBC (Ferrozine)